Skip to main content
NCD 110.9 · version 1

NCD 110.9: Antigens Prepared for Sublingual Administration

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 110.9

Benefit category
Antigens
Effective date
11/17/1996
Transmittal
Transmittal 90
Versions published
1
Manual section
110
Hematology/Immunology/Oncology, NCD Manual (Pub. 100-03) chapter 1 part 2

TL;DR

NCD 110.9 sets Medicare's national policy for antigens prepared for sublingual administration under the benefit category "Antigens", effective 11/17/1996. For antigens provided to patients on or after November 17, 1996, Medicare does not cover such antigens if they are to be administered sublingually, i.e., by placing drops under the patient's tongue. This kind of allergy therapy has not been proven to be safe… It has been revised once since publication and binds every Medicare Administrative Contractor nationally.

Indications and limitations of coverage

For antigens provided to patients on or after November 17, 1996, Medicare does not cover such antigens if they are to be administered sublingually, i.e., by placing drops under the patient's tongue. This kind of allergy therapy has not been proven to be safe and effective. Antigens are covered only if they are administered by injection.

Text reproduced from the CMS Medicare Coverage Database record for NCD 110.9 version 1. View the original on cms.gov.

Local policies that build on this NCD

7 active Local Coverage Determinations cite NCD 110.9 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

  • Allergen Immunotherapy, LCD L36240 · Novitas Solutions, Inc.
  • Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) (L40048) · Wellpoint Federal
  • L36408 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) · Wisconsin Physicians Service Insurance Corporation
  • L37800 Allergen Immunotherapy · First Coast Service Options, Inc.
  • L40046 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) · Palmetto GBA
  • L40050 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) · Noridian Healthcare Solutions, LLC
  • L40056 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) · CGS Administrators, LLC

How MACs bill NCD 110.9

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 2 current articles in the Medicare Coverage Database name NCD 110.9, 2 of them with a covered ICD-10-CM list, from 2 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

Contractors with articles that implement NCD 110.9
ContractorArticles
Noridian Healthcare Solutions, LLCA59976
Wellpoint FederalA59973

A59973: Billing and Coding: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)

Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

26 covered ICD-10-CM codes; 5 procedure codes: 95115, 95117, 95144, 95165, 95180. Local policy: L40048 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT). Check a diagnosis for 95115.

First covered codes: H10.10 Acute atopic conjunctivitis, unspecified eye; H10.11 Acute atopic conjunctivitis, right eye; H10.12 Acute atopic conjunctivitis, left eye; H10.13 Acute atopic conjunctivitis, bilateral; H10.45 Other chronic allergic conjunctivitis; J30.1 Allergic rhinitis due to pollen; …

A59976: Billing and Coding: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)

Billing and Coding, effective 2025-11-06 · Noridian Healthcare Solutions, LLC (01111, 01112, 01182, 01211, 01212, 01311, 01312, 01911, 02101, 02102, 02201, 02202, 02301, 02302, 02401, 02402, 03101, 03102, 03201, 03202, 03301, 03302, 03401, 03402, 03501, 03502, 03601, 03602) · CMS record

26 covered ICD-10-CM codes; 5 procedure codes: 95115, 95117, 95144, 95165, 95180. Local policy: L40050 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT). Check a diagnosis for 95115.

First covered codes: H10.10 Acute atopic conjunctivitis, unspecified eye; H10.11 Acute atopic conjunctivitis, right eye; H10.12 Acute atopic conjunctivitis, left eye; H10.13 Acute atopic conjunctivitis, bilateral; H10.45 Other chronic allergic conjunctivitis; J30.1 Allergic rhinitis due to pollen; …

Revision history

10/1996 - Provided noncoverage policy. Effective date 11/17/1996. (TN 90)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 110.9

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 110.9

What does NCD 110.9 cover?

For antigens provided to patients on or after November 17, 1996, Medicare does not cover such antigens if they are to be administered sublingually, i.e., by placing drops under the patient's tongue. This kind of allergy therapy has not been proven to be safe and effective. Antigens are covered only if they are administered by injection. The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 110.9 take effect?

The current version (1) is effective 11/17/1996, published in transmittal 90. This is the only published version.

Does a Local Coverage Determination override NCD 110.9?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.